CIBC Bancorp USA’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102M Sell
1,190,108
-34,007
-3% -$3.08M 0.13% 155
2026
Q2
$112M Buy
1,224,115
+73,738
+6% +$6.45M 0.14% 150
2026
Q1
$98M Buy
+1,150,377
New +$103M 0.13% 150
2025
Q3
$24.2M Buy
+303,218
New +$25.9M 0.13% 124

Other funds holding CL

CIBC Bancorp USA's CL Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Colgate-Palmolive (CL) stake by 2.8% in Q3 2026, selling an estimated $3.08M and leaving 1,190,108 shares worth $102M. The position accounts for 0.13% of the portfolio, ranked #155.

CIBC Bancorp USA first reported a position in CL in Q3 2025 and has held it in 4 quarters since. The position peaked at $112M in Q2 2026. 1,939 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • CIBC Bancorp USA held 1,190,108 shares of Colgate-Palmolive worth $102M as of Q3 2026.
  • CIBC Bancorp USA sold 34,007 Colgate-Palmolive shares in Q3 2026, an estimated $3.08M.
  • Colgate-Palmolive made up 0.13% of CIBC Bancorp USA's portfolio in Q3 2026, its #155 holding.
  • CIBC Bancorp USA first reported a position in Colgate-Palmolive in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Colgate-Palmolive position peaked at $112M in Q2 2026.
  • 1,939 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.